Increasing PrEP uptake among Latino men who have sex with men in Puerto Rico
Official title: Optimizing PrEP Uptake Among Latino MSM in Puerto Rico: A Comparative Effectiveness Study
Run by University of Puerto Rico · NCT05804461 · Data updated 2026-11-12
This study is trying out a new way to encourage Latino men who have sex with men in Puerto Rico to use PrEP, a medication that helps prevent HIV, by addressing their concerns and barriers to access.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 99 Years |
| Sex | Men only |
| Enrollment | 182 (estimated) |
| Sponsor | University of Puerto Rico Academic / other |
| Locations | 1 site (San Juan) |
| Status | Recruiting |
| Started | September 1, 2023 |
| Main results expected | May 31, 2027 |
| Study ends | May 31, 2027 |
| Registry record updated | July 15, 2026 |
| Trial ID | NCT05804461 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are Latino MSM aged 21 and older who are HIV-negative or have an unknown status and meet CDC criteria for PrEP eligibility.
✕Probably not a fit
Patients who are HIV positive or unable to read and write in Spanish will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to develop and evaluate a Motivational Interviewing Intervention designed to enhance the uptake of Pre-Exposure Prophylaxis (PrEP) among Latino men who have sex with men (MSM) in Puerto Rico. The intervention will focus on addressing barriers to PrEP access and adherence, utilizing motivational interviewing techniques to engage participants effectively. Eligible participants include HIV-negative or unknown status Latino MSM aged 21 and older who meet specific criteria for PrEP use. The study will be conducted at the University of Puerto Rico Medical Sciences Campus.
Why it matters
Potential benefit: If successful, this study could significantly increase PrEP uptake among Latino MSM, thereby reducing the risk of HIV transmission in this population.
How similar studies have gone: Other studies have shown success in using motivational interviewing to improve health outcomes, suggesting this approach may be effective in increasing PrEP uptake.
Who can join: the full rules
Show full inclusion / exclusion criteria
Latino MSM group - Inclusion Criteria: * Biological male * Age 21 or older * Self-reported HIV negative or unknown status * Not using PrEP (participants who have discontinued PrEP use can participate in the study), Spanish fluency (ability to write and read in Spanish) * Presenting at least one of the eligibility criteria for PrEP as established by the CDC (including men who have had an infection (STI) in the past 6 months, HIV positive sexual partner) * Access to a portable technology device (e.g., phone, tablet, laptop) or desktop computer access to internet connection Exclusion Criteria: * HIV positive individual * Evidence of being under the effects of alcohol or drugs * Indication of unstable or serious psychiatric symptoms * Evidence of major cognitive impairment * Inability to speak and read in Spanish Healthcare Providers group - Inclusion Criteria: * Age 21 or older * Providing PrEP related health services at time of enrollment (e.g., case management, clinical services) * Spanish fluency (ability to write and read in Spanish) Exclusion Criteria: * Evidence of being under the effects of alcohol or drugs * Indication of unstable or serious psychiatric symptoms * Evidence of major cognitive impairment * Inability to speak and read in Spanish
Where it's running
-
University of Puerto Rico Medical Sciences Campus
San Juan, Puerto Rico Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pharmacist-guided PEP/PrEP Access Using PEPPI Software
This trial tests whether the PEPPI software helps pharmacists provide PEP/PrEP and helps patients access these HIV prevention options.
-
Feasibility of Online HIV Prevention Research for People Who Inject Drugs
This study tests whether online recruitment and at-home HIV testing can be done reliably by and for people who inject drugs.
-
Host-led harm reduction for men who have sex with men who engage in chemsex in Bangkok
This project will try a host-led harm reduction approach to reduce substance-related, sexual, mental health, and legal harms among men who have sex with men who engage in chemsex in Bangkok.
-
Transgender-tailored harm reduction and PrEP service for people who engage in chemsex in Bangkok
This project will try a comprehensive harm-reduction service tailored for transgender and non-binary adults in Bangkok who engage in chemsex or substance use to increase PrEP use, reduce HIV/STIs, and address mental health and socio-legal needs.
-
See if PrEP Choice helps young people start and stick with HIV prevention methods
This trial tests whether the PrEP Choice package helps 13-24 year-olds in the U.S. begin and continue using PrEP or DoxyPEP for HIV prevention.
-
Adding sexual-pleasure conversations to harm reduction services for MSM and transgender people who do chemsex in Thailand
This project will try using a 'Pleasuremeter' to guide sexual-pleasure conversations in harm reduction services for MSM and transgender people who engage in chemsex or substance use in Thailand to see if it improves sexual health, substance use, and related outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.